RB1 c.1447C>T ;(p.H483Y)

Variant ID: 13-48954326-C-T

NM_000321.2(RB1):c.1447C>T;(p.H483Y)

This variant was identified in 11 publications

View GRCh38 version.




Publications:


A bipartite graph-based expected networks approach identifies DDR genes not associated with TMB yet predictive of immune checkpoint blockade response.

Cell Reports. Medicine
Weir, William H WH; Mucha, Peter J PJ; Kim, William Y WY
Publication Date: 2022-05-17

Variant appearance in text: RB1: 1447C>T; His483Tyr
PubMed Link: 35584624
Variant Present in the following documents:
  • mmc2.xlsx, sheet 4
View BVdb publication page



Systematic Review of Molecular Biomarkers Predictive of Resistance to CDK4/6 Inhibition in Metastatic Breast Cancer.

Jco Precision Oncology
Asghar, Uzma S US; Kanani, Ruhi R; Roylance, Rebecca R; Mittnacht, Sibylle S
Publication Date: 2022-01

Variant appearance in text: RB1: H483Y
PubMed Link: 35005994
Variant Present in the following documents:
  • po-6-e2100002.pdf
View BVdb publication page



Identifying Potential Neoantigens for Cervical Cancer Immunotherapy Using Comprehensive Genomic Variation Profiling of Cervical Intraepithelial Neoplasia and Cervical Cancer.

Frontiers In Oncology
Bao, Chaohui C; An, Na N; Xie, Hong H; Xu, Ling L; Zhou, Boping B; Luo, Jun J; Huang, Wanqiu W; Huang, Jian J
Publication Date: 2021

Variant appearance in text: RB1: H483Y
PubMed Link: 34221990
Variant Present in the following documents:
  • Table_7.xlsx, sheet 1
  • Table_3.xlsx, sheet 1
View BVdb publication page



Circulating Tumor DNA Analyses Predict Disease Recurrence in Non-Muscle-Invasive Bladder Cancer.

Frontiers In Oncology
Zhang, Jinghua J; Dai, Daofeng D; Tian, Junqiang J; Li, Lifeng L; Bai, Jing J; Xu, Yaping Y; Wang, Zhiping Z; Tang, Aifa A
Publication Date: 2021

Variant appearance in text: RB1: 1447C>T; H483Y
PubMed Link: 33996580
Variant Present in the following documents:
  • Table_2.xlsx, sheet 1
View BVdb publication page



The Genomic Landscape of Actinic Keratosis.

The Journal Of Investigative Dermatology
Thomson, Jason J; Bewicke-Copley, Findlay F; Anene, Chinedu Anthony CA; Gulati, Abha A; Nagano, Ai A; Purdie, Karin K; Inman, Gareth J GJ; Proby, Charlotte M CM; Leigh, Irene M IM; Harwood, Catherine A CA; Wang, Jun J
Publication Date: 2021-07

Variant appearance in text: RB1: 1447C>T; H483Y
PubMed Link: 33482222
Variant Present in the following documents:
  • mmc1.xlsx, sheet 4
View BVdb publication page



Integrated molecular drivers coordinate biological and clinical states in melanoma.

Nature Genetics
Conway, Jake R JR; Dietlein, Felix F; Taylor-Weiner, Amaro A; AlDubayan, Saud S; Vokes, Natalie N; Keenan, Tanya T; Reardon, Brendan B; He, Meng Xiao MX; Margolis, Claire A CA; Weirather, Jason L JL; Haq, Rizwan R; Schilling, Bastian B; Stephen Hodi, F F; Schadendorf, Dirk D; Liu, David D; Van Allen, Eliezer M EM
Publication Date: 2020-12

Variant appearance in text: RB1: 1447C>T; H483Y
PubMed Link: 33230298
Variant Present in the following documents:
  • NIHMS1637640-supplement-SuppData1.xlsx, sheet 1
View BVdb publication page



Latest Overview of the Cyclin-Dependent Kinases 4/6 Inhibitors in Breast Cancer: The Past, the Present and the Future.

Journal Of Cancer
Chen, Xiu X; Xu, Di D; Li, Xingjiang X; Zhang, Jian J; Xu, Weilin W; Hou, Junchen J; Zhang, Wei W; Tang, Jinhai J
Publication Date: 2019

Variant appearance in text: RB1: H483Y
PubMed Link: 31777590
Variant Present in the following documents:
  • Main text
  • jcav10p6608.pdf
View BVdb publication page



Pan-cancer whole-genome analyses of metastatic solid tumours.

Nature
Priestley, Peter P; Baber, Jonathan J; Lolkema, Martijn P MP; Steeghs, Neeltje N; de Bruijn, Ewart E; Shale, Charles C; Duyvesteyn, Korneel K; Haidari, Susan S; van Hoeck, Arne A; Onstenk, Wendy W; Roepman, Paul P; Voda, Mircea M; Bloemendal, Haiko J HJ; Tjan-Heijnen, Vivianne C G VCG; van Herpen, Carla M L CML; Labots, Mariette M; Witteveen, Petronella O PO; Smit, Egbert F EF; Sleijfer, Stefan S; Voest, Emile E EE; Cuppen, Edwin E
Publication Date: 2019-11

Variant appearance in text: RB1: His483Tyr
PubMed Link: 31645765
Variant Present in the following documents:
  • 41586_2019_1689_MOESM10_ESM.xlsx, sheet 1
View BVdb publication page



Osteosarcoma without prior retinoblastoma related to RB1 low-penetrance germline pathogenic variants: A novel type of RB1-related hereditary predisposition syndrome?

Molecular Genetics & Genomic Medicine
Imbert-Bouteille, Marion M; Gauthier-Villars, Marion M; Leroux, Dominique D; Meunier, Isabelle I; Aerts, Isabelle I; Lumbroso-Le Rouic, Livia L; Lejeune, Sophie S; Delnatte, Capucine C; Abadie, Caroline C; Pujol, Pascal P; Houdayer, Claude C; Corsini, Carole C
Publication Date: 2019-12

Variant appearance in text: RB1: His483Tyr
PubMed Link: 31568710
Variant Present in the following documents:
  • Main text
  • MGG3-7-e913.pdf
View BVdb publication page



Circulating tumour DNA analyses reveal novel resistance mechanisms to CDK inhibition in metastatic breast cancer.

Annals Of Oncology : Official Journal Of The European Society For Medical Oncology
Abbosh, C C; Swanton, C C; Birkbak, N J NJ
Publication Date: 2018-03-01

Variant appearance in text: RB1: His483Tyr
PubMed Link: 29351578
Variant Present in the following documents:
  • Main text
  • mdy017.pdf
View BVdb publication page



Defective splicing of the RB1 transcript is the dominant cause of retinoblastomas.

Human Genetics
Cygan, Kamil J KJ; Soemedi, Rachel R; Rhine, Christy L CL; Profeta, Abraham A; Murphy, Eileen L EL; Murray, Michael F MF; Fairbrother, William G WG
Publication Date: 2017-09

Variant appearance in text: RB1: 1447C>T
PubMed Link: 28780672
Variant Present in the following documents:
  • Main text
View BVdb publication page